Michael Swartzburg

Prior to joining Dermavant, Mr. Swartzburg most recently served as Vice President of Finance and in Principal Financial and Accounting Officer roles at Iovance Biotherapeutics, where he participated in over $1 billion in equity raises. Before Iovance, Mr. Swartzburg provided CFO and board advisory services at various biotech companies and served as Vice President of Finance, Controller and Principal Accounting Officer at Adverum Biotechnologies, where he was part of the team that steered Adverum through their successful IPO. He began his career as a Certified Public Accountant and auditor at Ernst & Young in Los Angeles.